Skip to main content
Log in

Insulin analogues and carcinoma of the breast

  • Letter to the Editors
  • Published:
Diabetologia Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Nielsen FS, Jorgensen LN, Ipsen M, Voldsgaard AI, Parving H-H (1995) Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen. Diabetologia 38: 592–598

    Article  PubMed  Google Scholar 

  2. Drejer K (1992) The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diabetes Metab Rev 8: 259–286

    PubMed  Google Scholar 

  3. LeRoith D, Werner H, Beitner-Johnson D, Roberts CTJ (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16: 143–163

    Article  PubMed  Google Scholar 

  4. Ebeling P, Koivisto VA (1994) Physiological importance of dehydroepiandrosterone. Lancet 343: 1479–1481

    Article  PubMed  Google Scholar 

  5. Valadares JRE, Singhal RL, Parulekar MR (1968) 17Β-estradiol: inducer of uterine hexokinase. Science 159: 990–991

    PubMed  Google Scholar 

  6. Singhal RL, Valadares JRE, Ling GM (1969) Estrogenic regulation of uterine carbohydrate metabolism during senescence. Am J Physiol 217: 793–797

    PubMed  Google Scholar 

  7. Martikainen H, Koistinen R, SeppÄlÄ M (1992) The effect of estrogen level on glucose-induced changes in serum insulin-like growth factor binding protein-1 concentration. Fertil Steril 58: 543–546

    PubMed  Google Scholar 

  8. Manni A, Wright C, Buck H (1991) Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar. Breast Cancer Res Treat 20: 43–52

    PubMed  Google Scholar 

  9. Huynh H, Pollak M (1994) Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue. Biochem Biophys Res Commun 203: 253–259

    Article  PubMed  Google Scholar 

  10. Weckbecker G, Liu R, Tolcsvai L, Burns C (1992) Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro. Cancer Res 52: 4973–4978

    PubMed  Google Scholar 

  11. Ramalingam V, Krishnamoorthy G, Govindarajulu P (1994) Enzymes of carbohydrate metabolism in human breast carcinoma: relationship with serum hormones. Neoplasma 41: 49–54

    PubMed  Google Scholar 

  12. Yamamoto H, Aikawa T, Matsutaka H, Okuda T, Ishikawa E (1974) Interorgan relationships of amino acid metabolism in fed rats. Am J Physiol 226: 1428–1433

    PubMed  Google Scholar 

  13. Falholt K, Cutfield R, Alejandro R, Voelund A, Heding LG, Mintz DH (1991) Influence of portal delivery of insulin on intracellular glucose and lipid metabolism. Metabolism 40: 122–126

    Article  PubMed  Google Scholar 

  14. Raineri R, Levy HR (1970) On the specificity of steroid interaction with mammary glucose 6-phosphate dehydrogenase. Biochemistry 9: 2233–2243

    PubMed  Google Scholar 

  15. Farquharson C, Milne J, Loveridge N (1993) Mitogenic action of insulin-like growth factor-I on human osteosarcoma MG-63 cells and rat osteoblasts maintained in situ: the role of glucose-6-phosphate dehydrogenase. Bone Miner 22: 105–115

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ebeling, P. Insulin analogues and carcinoma of the breast. Diabetologia 39, 124–125 (1996). https://doi.org/10.1007/BF00400425

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00400425

Keywords

Navigation